Evaluation of three estrus synchronization regimens for use in extensively managed Bos indicus and Bos indicus/taurus heifers in Northern Australia.

Article Details

Citation
Copy to clipboard

Kerr DR, McGowan MR, Carroll CL, Baldock FC

Evaluation of three estrus synchronization regimens for use in extensively managed Bos indicus and Bos indicus/taurus heifers in Northern Australia.

Theriogenology. 1991 Jul;36(1):129-41.

PubMed ID
16726986 [ View in PubMed
]
Abstract

Two herds of extensively managed yearling Bos indicus and Bos indicus x Bos taurus heifers (n=169) were assigned to one of three estrus synchronization treatment groups. The treatments consisted of 1) two injections of the prostaglandin (F2alpha) analogue, luprostiol (7.5 mg), given 12-d apart; 2) insertion of an intravaginal progesterone-releasing device (CIDR-B), followed by 400 IU i.m. pregnant mare serum gonadotrophin (PMSG) and 7.5 mg luprostinol at CIDR-B removal or 3) subcutaneous progestagen implant (SMB) for 10-d, followed by 400 IU i.m. and 7.5 mg i.m. luprostiol at implant removal. A dual tail paint-raddle system was used to evaluate response to treatment. Each treatment group was inseminated according to the manufacturer's recommendations for fixed-time artificial insemination (A.I.; luprostiol, 72 h after the second injection, SMB and CIDR-B 48h after implant/device removal). The overall 51-d pregnancy rates for the three treatments were 18.6% (luprostiol), 48.8% (CIDR-B), and 53.3% (SMB). There were significant differences in the pregnancy rate between CIDR-B and luprostiol (P=0.004) and between SMB and luprostiol (P=or<0.0001), but there was no difference in pregnancy rate between CIDR-B and SMB treatment.

DrugBank Data that Cites this Article

Drugs